Both compounds are among the most researched peptides for tissue repair and recovery, and the combination is studied for synergistic effects on healing speed, angiogenesis, and musculoskeletal recovery
Hormonal cycles in menstruating individuals can also amplify GI sensitivity
2022;377: e068882
Based on the typical UK regulatory pathway, the most realistic timeline is: Late 2026 / early 2027: Eli Lilly expected to submit regulatory filings to the FDA and MHRA following completion of the remaining TRIUMPH Phase 3 readouts Late 2027 to mid-2028: Possible MHRA marketing authorisation, allowing private UK prescribing 2028 to 2029 onwards: Possible NHS availability following a NICE technology appraisal and NHS commissioning decisions Timelines may differ across the four UK nations, as Scotland, Wales, and Northern Ireland assess medicines separately through the Scottish Medicines Consortium (SMC), All Wales Medicines Strategy Group (AWMSG), and the Department of Health Northern Ireland respectively
Thyroid medications may require timing adjustments
However, we dont have a strong, singular reason to recommend them over providers that can do the same at a lower cost